Style
Deep ValueTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Monte Rosa Therapeutics, Inc.(GLUE) | 3,180,780 | $77.0M | 47.34% |
| 2 | Century Therapeutics, Inc.(IPSC) | 12,166,109 | $29.8M | 18.33% |
| 3 | Jade Biosciences, Inc.(JBIO) | 991,783 | $22.0M | 13.55% |
| 4 | Lenz Therapeutics, Inc.(LENZ) | 2,656,888 | $15.1M | 9.28% |
| 5 | Contineum Therapeutics, Inc.(CTNM) | 542,628 | $8.9M | 5.47% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 94.68% | 94.82% | +0.14% |
| Unclassified | 5.32% | 5.18% | -0.14% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Crispr Therapeutics AG(CRSP) |
| 148,831 |
| $8.1M |
| 4.99% |
| 7 | Skye Bioscience, Inc.(SKYE) | 2,007,704 | $1.4M | 0.86% |
| 8 | Tempest Therapeutics, Inc.(OVASUSD) | 269,772 | $299.4K | 0.18% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Small Cap | 93.81% | 93.97% | +0.16% |
| Unclassified | 5.32% | 5.18% | -0.14% |
| Micro Cap | 0.87% | 0.86% | -0.01% |
Quarter-over-quarter position changes